Controlled myocardial infarction induced by intracoronary injection of n-butyl cyanoacrylatein dogs: A feasibility study

2005 ◽  
Vol 66 (2) ◽  
pp. 244-253 ◽  
Author(s):  
Gabor F. Matos ◽  
Rasheed Hammadeh ◽  
Christopher Francois ◽  
Richard McCarthy ◽  
Ferdinand Leya
Keyword(s):  
Myocardial Infarction ◽  
Feasibility Study ◽  
Intracoronary Injection

scholarly journals Time course of contrast enhancement patterns after Gd-BOPTA in correlation to myocardial infarction and viability: A feasibility study

2001 ◽  
Vol 14 (6) ◽  
pp. 789-794 ◽  
Author(s):  
Joern J.W. Sandstede ◽  
Meinrad Beer ◽  
Claudia Lipke ◽  
Thomas Pabst ◽  
Werner Kenn ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Contrast Enhancement ◽  
Feasibility Study ◽  
Time Course

Diagnosis of myocardial infarction based on lectin-induced erythrocyte agglutination: a feasibility study

2014 ◽  
Author(s):  
József Bocsi ◽  
Kathleen Nieschke ◽  
Anja Mittag ◽  
Thomas Reichert ◽  
Wiebke Laffers ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Feasibility Study

Forward and back aspiration during ST-elevation myocardial infarction: a feasibility study

2016 ◽  
Vol 11 (14) ◽  
pp. e1639-e1648 ◽  
Author(s):  
Vasim Farooq ◽  
Patrick W. Serruys ◽  
Ahmad H.S. Mustafa ◽  
Mamas A. Mamas ◽  
Nadim Malik ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Feasibility Study ◽  
St Elevation Myocardial Infarction ◽  
St Elevation

Home defibrillation: A feasibility study in myocardial infarction survivors at intermediate risk of sudden death

2006 ◽  
Vol 152 (4) ◽  
pp. 685.e1-685.e7 ◽  
Author(s):  
Tommaso Sanna ◽  
Francesco Fedele ◽  
Igino Genuini ◽  
Andrea Puglisi ◽  
Paolo Azzolini ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Sudden Death ◽  
Feasibility Study ◽  
Intermediate Risk

scholarly journals Dynamic Tracking During Intracoronary Injection of 18F-FDG-Labeled Progenitor Cell Therapy for Acute Myocardial Infarction

2007 ◽  
Vol 48 (10) ◽  
pp. 1708-1714 ◽  
Author(s):  
B. Doyle ◽  
B. J. Kemp ◽  
P. Chareonthaitawee ◽  
C. Reed ◽  
J. Schmeckpeper ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Cell Therapy ◽  
Progenitor Cell ◽  
Intracoronary Injection ◽  
Dynamic Tracking ◽  
18F Fdg

scholarly journals Fast, three-dimensional free-breathing MR imaging of myocardial infarction: A feasibility study

2004 ◽  
Vol 51 (5) ◽  
pp. 1055-1060 ◽  
Author(s):  
Manojkumar Saranathan ◽  
Carlos E. Rochitte ◽  
Thomas K.F. Foo
Keyword(s):  
Myocardial Infarction ◽  
Mr Imaging ◽  
Feasibility Study ◽  
Three Dimensional ◽  
Free Breathing

Abstract 4305: Long-term Follow-up Of Left Ventricular Function After Acute Myocardial Infarction Treated With Intracoronary Injection Of Autologous Bone Marrow Cells. The ASTAMI Study

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Jan Otto Beitnes ◽  
Einar Hopp ◽  
Ketil Lunde ◽  
Hans-Jørgen Smith ◽  
Svein Solheim ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Bone Marrow ◽  
Left Ventricular Function ◽  
Bone Marrow Cells ◽  
Left Ventricular ◽  
Intracoronary Injection ◽  
Significant Difference

Background: Long-term effects of cardiac autologous cell therapy are not well known. We performed a 3 year follow-up of the ASTAMI study. Patients with acute ST-elevation anterior wall myocardial infarctions were initially randomized to either intracoronary injection of autologous mononuclear bone marrow cells (mBMCs) (n=50) or control (n=50). At 6 months, LV ejection fraction improved in both groups, with no significant difference between groups. Methods: All eligible patients underwent MRI with a 1,5 T scanner (Siemens) 2–3 weeks, 6 months and mean(SD) 3,2 (0,2) years after myocardial infarction and stem cell injection. Infarct size was determined from gadolinium late-enhancement MR images. All images were analyzed by experienced observers blinded for treatment assignment. Left ventricular volumes were calculated by the area-length method. Results: There was no significant difference in EDV, ESV or LVEF between baseline and 3 years in neither group. Infarction volume was reduced at 3 years in both groups (p<0,001). No significant effects of mBMC treatment could be identified on LV volumes, LVEF or infarct size. Thus intracoronary injection of mBMCs in acute myocardial infarction does not improve global LV function over a 3 year follow-up. Left ventricular function after mBMC-treatment

Sign in / Sign up

Export Citation Format

Share Document